Concerns have been raised that problems related to the supply of a substance used to screen for cancerous cells is causing delays for NHS patients in England, with many exposed to repeated cancellation of scans at short notice.
Choline is a radiotracer injected into patients an hour before PET-CT scans, predominately when patients are feared to have a recurrence of prostate cancer. Without it the scans cannot go ahead.
The worries surrounding its availability come as waiting times for cancer patients in England are at a record high, with almost one in four patients not starting treatment within the two-month target period.
Full Story: The Guardian, 7th April 2019